LipoCheck Lands €2.5M Seed Round to Revolutionize Lipödem Diagnosis and Empower Women's Health

LipoCheck, an innovative startup in the digital healthcare space, has just raised 2.5 million euros in a funding round aimed at revolutionizing the diagnosis and treatment of Lipödem—a condition that affects nearly one in every ten women. For far too long, countless women have endured years, sometimes even a lifetime, of physical and emotional suffering due to misdiagnosis and incomplete therapies, placing an enormous burden on the healthcare system. With this new injection of capital, LipoCheck is poised to dramatically accelerate its mission of transforming care for women affected by Lipödem. The company is developing the first-ever digital, AI-driven platform designed to aid both patients and doctors. At the heart of this innovative solution is an app that leverages advanced artificial intelligence to accurately detect and objectively assess Lipödem symptoms. This breakthrough tool not only supports early and precise diagnosis but also continuously documents patient progress, enabling healthcare professionals to tailor therapies more effectively. The ultimate goal is to empower millions of women with daily support—from initial recognition through to comprehensive management of their symptoms—while simultaneously relieving pressure on a healthcare system that has long struggled with lengthy waitlists and a shortage of experts in the field. By bridging the gap between patient needs and medical expertise, LipoCheck is setting a new standard for personalized and accessible care. With this significant funding achievement, the company is well on its way to transforming a previously overlooked area of women’s health, offering renewed hope and an improved quality of life to those affected by Lipödem.